Takeda has said approval of its dengue fever vaccine in Indonesia marks a big step towards the company’s goal of creating a global vaccine business that would compete with larger rivals such as GSK, Sanofi and Merck.
武田药品(Takeda)表示，其登革热疫苗在印尼获得批准，标志着该公司朝着创建manbetx app苹果 疫苗业务、与葛兰素史克(GSK)、赛诺菲(Sanofi)和默克(Merck)等规模更大的对手竞争的目标迈出了一大步。
您已阅读5%（317字），剩余95%（5746字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。